ロード中...
Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations
Many patients with chronic kidney disease (CKD) receive anticoagulation or antiplatelet therapy due to atrial fibrillation, coronary artery disease, thromboembolic disease, or peripheral artery disease. The treatment usually includes vitamin K antagonists (VKAs) and/or platelet aggregation inhibitor...
保存先:
| 出版年: | Int J Nephrol Renovasc Dis |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5473496/ https://ncbi.nlm.nih.gov/pubmed/28652799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S105771 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|